Clinical trial
Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic…
NCT00339703 · 59th Medical Wing, U.S. Fed · Completed
Key facts
| NCT number | NCT00339703 |
|---|---|
| Title | Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State. |
| Official title | Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State. |
| Lead sponsor | 59th Medical Wing, U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Asthma |
| Enrollment | 44 |
| Start date | Nov 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jun 21, 2006 |
| Last update posted | Jan 19, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: